TWIL
GMED icon

TrueNorth Wealth & Impact, LLC’s Globus Medical GMED Stock Holding History

TrueNorth Wealth & Impact, LLC’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Buy
+2,684
New +$213K 0.08% 178

Other funds holding GMED

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

TrueNorth Wealth & Impact, LLC's GMED Position: Q3 2026 in Review

TrueNorth Wealth & Impact, LLC opened a new position in Globus Medical (GMED) in Q3 2026: 2,684 shares worth $201K. The stake represents 0.08% of the portfolio and ranks #178 among its holdings.

512 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • TrueNorth Wealth & Impact, LLC held 2,684 shares of Globus Medical worth $201K as of Q3 2026.
  • Globus Medical was a new TrueNorth Wealth & Impact, LLC position in Q3 2026.
  • Globus Medical made up 0.08% of TrueNorth Wealth & Impact, LLC's portfolio in Q3 2026, its #178 holding.
  • 512 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on TrueNorth Wealth & Impact, LLC's 13F filing for Q3 2026, filed 13 Nov 2026.